Takeda Ventures, Inc.
Investment Details
Investor Type
Corporate VC
Asset Class Focus
Venture Capital
Stage Focus
Pre-Seed, Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United States, Canada, Japan, Australia, Europe, China, India, Brazil, United Arab Emirates, Mexico, South Korea, Saudi Arabia, Egypt, Turkey, South Africa, Israel, Chile, Argentina, Colombia, Peru
Industries Focus
- Healthcare
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Medical Research
- Oncology
- Neurology
- Cardiology
- Endocrinology
- Immunology
- Genomics
- Pulmonology
- Rheumatology
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2001
Takeda Ventures, Inc. is the corporate venture capital arm of Takeda Pharmaceutical Company Limited, established in 2001 to generate disruptive technologies and therapeutic solutions for patients through venture-based investments. The firm focuses on high-caliber, therapeutic, platform-based companies worldwide, specifically investing in early-stage, preclinical opportunities that complement Takeda’s pipeline. Its mission is to create strategic growth opportunities for Takeda by building, managing, and investing in innovative companies.
The investment strategy of Takeda Ventures centers on areas aligned with Takeda’s R&D pillars, including Oncology, Rare Genetics & Hematology, Neuroscience, and Gastrointestinal and Inflammation. By partnering with academic innovators, entrepreneurs, and venture investors, Takeda Ventures aims to support therapeutic innovation by providing access to the resources of a multinational pharmaceutical company. This approach fosters the development of novel treatments and accelerates the advancement of promising therapies.
With a global presence, Takeda Ventures operates alongside Takeda’s R&D sites in Cambridge, Massachusetts, and San Diego, California. The firm emphasizes collaborative interactions that result in synergies with Takeda's considerable R&D resources, striving to build a portfolio of strategic investments that drive innovation and address unmet medical needs across various therapeutic areas.
Requirements
- Innovative biotechnology and pharmaceutical companies
- Early-stage, preclinical opportunities
- Alignment with Takeda’s R&D pillars: Oncology, Rare Genetics & Hematology, Neuroscience, Gastrointestinal and Inflammation
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- CellCentric
- Symphogen
- Xenon Pharmaceuticals
Mentioned In
Claim this Investor
Are you an official representative of Takeda Ventures, Inc.?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim